GlassScriptPhysician profile
Audrey M Page
NPI 1376777466
$4,772.13
in general payments reported to CMS, 2019-2025
40 companies · $707 in 2025
The $707 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $360 · 2021: $558 · 2022: $1,067 · 2023: $648 · 2024: $986 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.41 | 2019-2024 | |
| Pfizer INC. | $444.02 | 2019-2025 | |
| Daiichi Sankyo INC. | $318.76 | 2020-2025 | Injectafer |
| Biogen, INC. | $303.01 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $286.29 | 2019-2025 | Slynd |
| Shield Therapeutics INC | $271.27 | 2022-2025 | Accrufer |
| Astellas Pharma US INC | $216.59 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $203.55 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $197.02 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $196.76 | 2019-2022 | |
| Hologic Sales and Service, LLC | $184.05 | 2022-2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $176.65 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.21 | 2020-2025 | |
| Aspira Women'S Health INC | $117.47 | 2022-2023 | Ova1 |
| Scynexis, INC. | $89.99 | 2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $88.63 | 2024 | |
| Therapeuticsmd, INC. | $86.31 | 2019-2022 | |
| Duchesnay USA Incorporated | $76.34 | 2019 | |
| Millicent US INC | $76.29 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Mylan Pharmaceuticals INC. | $65.35 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $64.67 | 2024 | Exparel |
| Bausch Health US, LLC | $59.53 | 2019-2020 | |
| Avion Pharmaceuticals | $57.91 | 2020-2023 | Balcoltra |
| Agile Therapeutics, INC. | $57.53 | 2021-2024 | Twirla |
| Novo Nordisk INC | $39.05 | 2021-2022 | |
| Axonics, INC. | $37.78 | 2024 | Bulkamid |
| Coopersurgical, INC. | $37.18 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Medtronic, INC. | $33.90 | 2024-2025 | Interstim, Truclear |
| Monaghan Medical Corporation | $31.88 | 2024 | Aerochamber |
| Virtus Pharmaceuticals LLC | $28.30 | 2021 | |
| Gynesonics, INC. | $25.11 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Northgate Technologies, INC. | $23.22 | 2024 | Stimsite |
| Optumhealth Care Solutions, LLC | $22.71 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Davol INC. | $22.57 | 2023 | Arista Ah Flexitip |
| Becton, Dickinson and Company | $19.75 | 2020 | |
| Merck Sharp & Dohme LLC | $15.30 | 2022 | |
| Allergan, INC. | $14.36 | 2019 | |
| Hologic INC | $13.40 | 2021 | |
| Lupin INC. | $13.21 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.